Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
ArcelorMittal
MT
$46B
| $120M | 0.1% |
11,156,719
+3,686,985
| +49% | +$37.2M |
2017 Q3
11 quarters
|
|
202
Innoviva
INVA
$1.51B
| $119M | 0.1% |
8,530,811
+326,800
| +4% | +$4.45M |
2017 Q3
11 quarters
|
|
203
Aecom
ACM
$7.57B
| $119M | 0.1% |
3,165,115
-1,337,900
| -30% | -$47.9M |
2019 Q1
5 quarters
|
|
204
NovoCure
NVCR
$1.64B
| $119M | 0.1% |
2,000,570
-244,900
| -11% | -$16.1M |
2017 Q4
10 quarters
|
|
205
Royal Gold
RGLD
$19.6B
| $118M | 0.1% |
950,842
+285,534
| +43% | +$34.5M |
2019 Q2
4 quarters
|
|
206
Enphase Energy
ENPH
$4.3B
| $116M | 0.1% |
2,435,961
+95,176
| +4% | +$4.55M |
2019 Q1
5 quarters
|
|
207
Universal Display
OLED
$3.37B
| $116M | 0.1% |
772,639
+110,000
| +17% | +$16.1M |
2019 Q3
3 quarters
|
|
|
JNPR
208
DELISTED
Juniper Networks
JNPR
| $115M | 0.1% |
5,026,692
+1,225,600
| +32% | +$28.2M |
2014 Q1
25 quarters
|
|
209
Gentex
GNTX
$4.44B
| $114M | 0.1% |
4,442,235
+238,300
| +6% | +$5.97M |
2017 Q2
12 quarters
|
|
|
ACIA
210
DELISTED
Acacia Communications Inc
ACIA
| $113M | 0.1% |
1,687,659
+1,253,900
| +289% | +$85M |
2018 Q4
6 quarters
|
|
211
C.H. Robinson
CHRW
$16.4B
| $113M | 0.1% |
1,430,913
+1,197,220
| +512% | +$90.4M |
2020 Q1
1 quarter
|
|
|
FISV
212
Fiserv Inc
FISV
$24.2B
| $113M | 0.1% |
+1,156,427
| New | +$116M |
2020 Q2
0 quarters
|
|
213
Flowers Foods
FLO
$1.23B
| $113M | 0.1% |
5,031,972
+285,300
| +6% | +$6.43M |
2017 Q2
12 quarters
|
|
|
ECHO
214
EchoStar
ECHO
$27.3B
| $110M | 0.1% |
3,936,801
+233,400
| +6% | +$7.09M |
2013 Q2
28 quarters
|
|
|
XYZ
215
Block Inc
XYZ
$45B
| $110M | 0.09% |
1,045,200
+526,200
| +101% | +$40.3M |
2019 Q4
2 quarters
|
|
|
AMTD
216
DELISTED
TD Ameritrade Holding Corp
AMTD
| $109M | 0.09% |
3,006,528
-2,760,792
| -48% | -$104M |
2018 Q4
6 quarters
|
|
217
AB InBev
BUD
$152B
| $109M | 0.09% |
2,210,176
-417,800
| -16% | -$19.5M |
2015 Q3
19 quarters
|
|
218
Telkom Indonesia
TLK
$12.7B
| $109M | 0.09% |
4,975,914
+179,700
| +4% | +$3.8M |
2014 Q4
22 quarters
|
|
219
Berkshire Hathaway Class A
BRK.A
$1.1T
| $109M | 0.09% |
406
+328
| +421% | +$89.9M |
2015 Q1
21 quarters
|
|
220
Commault Systems
CVLT
$6.28B
| $108M | 0.09% |
2,788,887
+558,200
| +25% | +$22.1M |
2013 Q2
28 quarters
|
|
221
Marriott International
MAR
$94.4B
| $108M | 0.09% |
1,258,016
+1,115,800
| +785% | +$96.9M |
2020 Q1
1 quarter
|
|
222
TripAdvisor
TRIP
$1.03B
| $108M | 0.09% |
5,671,384
+1,566,500
| +38% | +$29.9M |
2018 Q3
7 quarters
|
|
223
Morningstar
MORN
$7.65B
| $107M | 0.09% |
759,470
+41,900
| +6% | +$5.92M |
2013 Q2
28 quarters
|
|
224
UDR
UDR
$10.8B
| $107M | 0.09% |
2,863,416
-1,396,090
| -33% | -$52.1M |
2014 Q3
23 quarters
|
|
225
BCE
BCE
$18.6B
| $107M | 0.09% |
2,556,889
-11,900
| -0.5% | -$490K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.